Torreya Partner’s first closed sale assignment was the sale of a generic pharmaceutical company to Hi-Tech Pharmacal. Since then, we have continued to work intensely on a variety of projects in the generic pharmaceutical sector.
Our work has involved a variety of projects in generics that include:
- Sale of generic marketer in the United States
- Acquisition of manufacturing facilities in injectibles
- Survey of acquisition opportunities in liquid generics
- Disposal of late stage ANDAs
- Sale of commercial stage injectible products
The generic pharma field is undergoing a period of high growth—driven by innovation in formulation technology and systemwide pressures to substitute generics for branded products.
The field of generic pharmaceutical development has rapidly globalized with profound implications for all players. We have been involved in recent years in project work with generic pharmaceutical companies based in North America, Europe, India, China and Latin America.